The fine is about 10 percent of Illumnia’s revenue last year; the company had set aside capital to prepare for the fine. Illumina plans to appeal the decision and described the fine as “disproportionate.”
Illumina finalized its purchase of Grail in August 2021. In April 2023, the Federal Trade Commission ordered Illumina to divest from Grail.
“If companies merge before our clearance, they breach our rules,” EU Competition Commissioner Margrethe Vestager said. “Illumina and Grail knowingly and deliberately did so by implementing their tie-up as we were still investigating.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.